Navigation Links
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
Date:6/10/2009

d by Calvert T1 combine the known anti-proliferative effects of a somatostatin peptide analog with a cytotoxic drug chemically linked to the peptide, resulting in a dual mechanism drug candidate designed to specifically target and kill abnormal blood vessels found in wet AMD patients.

The lead compound from this technology platform has shown activity in an animal model of AMD. Calvert T1 intends to advance it further through additional preclinical studies using its network of preferred pharmaceutical development service providers including Calvert Laboratories, Inc., a leading contract laboratory offering toxicology, pharmacology, immunology, pharmacokinetic and other preclinical services to the biotechnology and pharmaceutical industry.

Russ C. McLauchlan, Chairman and CEO of Calvert Holdings commented: "We are very pleased to enter into this agreement with Dr. Coy and his colleagues at Tulane to further develop this very promising technology for the treatment of wet AMD. This disease is of growing concern to millions of people as our population ages. Calvert has a strong commitment to work with research universities such as Tulane to advance these research efforts." He added: "Calvert T1 is a continuation of investments in a range of technologies over the last several years. Other investments include the following: CureDM (Lankenau Institute) for diabetes, Auburn University for targeted drug delivery, Pinnacle Pharmaceuticals (University of Virginia) for wound healing, and AcSentient II (now owned by Ista Pharmaceuticals, Inc.) for ocular hypertension/open-angle glaucoma.

About Tulane University:
Tulane University is one of the nation's leading educational and research institutions. Founded in 1834 in New Orleans, Tulane has ten schools and colleges offering degrees in architecture, busi
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Calvert Research and Auburn University Announce Joint Venture
2. Calvert Labs Announces the Hiring of Terry Ladd
3. Calvert Research and CureDM Sign Collaborative Agreement
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
7. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
8. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
9. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
10. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
11. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
(Date:6/26/2015)... , June 26, 2015 The ... Application (Hydraulic Fluids, Metalworking fluids, Chainsaw oils, Mold Release ... by Region - Global trends and Forecasts to 2020" ... reach $2,972.13 Million by 2020 at a CAGR of ... 160 market data Tables and   66 Figures spread ...
(Date:6/25/2015)... , June 25, 2015 ... ) has announced the addition of ... the Global Cancer Diagnostics Industry: Oncogenes, ... Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
(Date:6/25/2015)... ... 25, 2015 , ... Students entering the new Hemenway Hall ... each exclusively using filtered fume hoods that feature Erlab’s GreenFumeHood Filtration Technology ... hoods needed for their Organic, Inorganic, Analytical, and Physical Chemistry teaching laboratories. Each ...
(Date:6/25/2015)... England , June 25, 2015 /PRNewswire/ ... von Arzneimittel-Überprüfungs- und -Authentifizierungsdienstleistungen, führte am 24. ... Frankfurt am Main das 2. ... umfassende Informations-Veranstaltung zum Thema Sicherheit für Patienten ... -.      (Logo: http://photos.prnewswire.com/prnh/20150610/748687) , ...
Breaking Biology Technology:Biolubricants Market Worth $2,972.13 Million by 2020 2Biolubricants Market Worth $2,972.13 Million by 2020 3Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains 2Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains 3This Summer Erlab Completes the Largest Installation of Filtered Fume Hoods in the World 2Symposium zur Richtlinie über gefälschte Arzneimittel - mit Aegate in Deutschland 2Symposium zur Richtlinie über gefälschte Arzneimittel - mit Aegate in Deutschland 3
... 6 /Xinhua-PRNewswire-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin ... leading manufacturer and distributor,of high-quality, pharmaceutical grade ... products that serve as raw materials for ... it will conduct a conference,call at 9:00 ...
... Expands the Company,s Clinical Stage Product Portfolio ... Meditrina Pharmaceuticals,Inc. today announced that it ... make, develop and commercialize products under AstraZeneca,s ... inhibitors (AI) in combination with,estrogen and progestin ...
... Inc. ("Senesco" or the "Company") (Amex: SNT ... focused on multiple myeloma that,were conducted concurrently at ... of these studies, which utilized two different dosing ... Factor 5A technology to induce,apoptosis in tumors. Additionally, ...
Cached Biology Technology:Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008 2Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008 3Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca 2Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca 3Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies 2Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies 3
(Date:6/12/2015)... 2015  Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring, announced the United ... capture, analyze and identify participants of a video ... This system can: , Identify ... subsequent sign-on process is actually the person participating ...
(Date:6/9/2015)... Minn. , June 9, 2015   MedNet ... supports the entire spectrum of clinical research, will be ... eClinical technology platform at the 2015 Drug Information Association ... on June 15-17.  These presentations will include previews ... rolled out in the upcoming iMedNet 2015 ...
(Date:6/8/2015)... June 8, 2015  The Secure Identity ... selection of Troy Potter of L-3 ... SIBA is a non-profit association that was established ... education and implementation of solutions that protect and ... ...
Breaking Biology News(10 mins):Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 4Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 5
... VANCOUVER, BRITISH COLUMBIA Parents of children with chronic ... to a study being presented Monday, May 3 at ... British Columbia, Canada. Medication use in children with ... been done on mistakes made by parents giving these ...
... in complex networks that govern cellular processes, much like people ... discovering how biological networks change and are rewired in cancer. ... ( www.genome.org ), scientists have analyzed the genetic networks ... awry in disease. MicroRNAs (miRNAs) are short RNA molecules ...
... , STANFORD, Calif. - Life is almost unbearably complex. ... and off in dizzying combinations and sequences during their ... to understand the machinations of the proteins behind the ... their disposal, courtesy of researchers at the Stanford University ...
Cached Biology News:Home medication errors common among children with chronic conditions 2MicroRNA network study implicates rewired interactions in cancer 2New Stanford tool enables wider analyses of genome 'deep sequencing' 2New Stanford tool enables wider analyses of genome 'deep sequencing' 3
BD Falcon insert HTS 96 well, square A-bottom with lid. PET membrane, sterile. (5/ca) Packaging: 5 / pack, 5 / case ...
... NIS-Elements revolutionizes imaging software for the ... to microscopes, cameras, components and peripherals ... achiving tools. Its intuitive interface simplifies ... times while providing powerful features such ...
...
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of poly-D-lysine....
Biology Products: